IIQ 8.80% 57.0¢ inoviq ltd

Ann: BARD1 Signs Option Agreement for Type 3C Diabetes Test, page-35

  1. 168 Posts.
    lightbulb Created with Sketch. 153
    @Davy Boy Firstly - sorry to hear about your sister.

    I agree that the diabetes group would the the target group for a T3cDM test without a doubt.

    A successful test there would then identify the highest risk people with diabetes for Pancreatic Cancer.

    Government funding for the programs would likely be to fund a T3cDM test for all those identified as having diabetes and then further funding could be provided to screen those who are then identified as even higher risk for Pancreatic Cancer.

    That's how I see it at this early stage.


 
watchlist Created with Sketch. Add IIQ (ASX) to my watchlist
(20min delay)
Last
57.0¢
Change
-0.055(8.80%)
Mkt cap ! $60.14M
Open High Low Value Volume
62.0¢ 62.0¢ 57.0¢ $43.03K 73.40K

Buyers (Bids)

No. Vol. Price($)
1 5999 57.0¢
 

Sellers (Offers)

Price($) Vol. No.
59.0¢ 92 1
View Market Depth
Last trade - 16.10pm 08/07/2024 (20 minute delay) ?
IIQ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.